BridgeBio Pharma, Inc. (2CL.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 04:05PM CEST
| Previous Close | 25.21 |
| Open | 26.44 |
| Bid | 26.69 x N/A |
| Ask | 27.24 x N/A |
| Day's Range | 26.44 - 26.52 |
| 52 Week Range | 12.19 - 39.72 |
| Volume | |
| Avg. Volume | 34 |
| Market Cap | 5.051B |
| Beta (5Y Monthly) | 1.08 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
What You Need To Know About The BridgeBio Pharma, Inc. (NASDAQ:BBIO) Analyst Downgrade Today
The latest analyst coverage could presage a bad day for BridgeBio Pharma, Inc. ( NASDAQ:BBIO ), with the analysts...
- Simply Wall St.
BridgeBio Pharma First Quarter 2024 Earnings: Beats Expectations
BridgeBio Pharma ( NASDAQ:BBIO ) First Quarter 2024 Results Key Financial Results Revenue: US$211.1m (up by US$209.3m...
- Zacks
Will BridgeBio Pharma (BBIO) Report Negative Q1 Earnings? What You Should Know
BridgeBio Pharma (BBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.